# Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

> **NCT00976768** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 44 (actual)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** oxaliplatin, 5-fluorouracil

## Key facts

- **NCT ID:** NCT00976768
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976768, "Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00976768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*